The intersection between competition law and patent law: the fingolimod case
Vidal-Quadras&Ramon has been recognized one more year by the leading directory Chambers and Partners
First judgment on damages for a pharmaceutical patent and the effect of price reduction (the raloxifene case)
On 23 June 2023, the Provincial Court of Madrid ruled for the first time in Spain on the question of which generic company should pay compensation for the price reduction of a reference product following a declaration of infringement of the patent rights protecting it. The ruling was issued by the 32nd Section specializing in …
The Proposed EU SEP Regulation: a new ecosystem in SEP licensing?
Last April, the European Commission presented three regulatory proposals arising out of the IP Action Plan adopted in November 2020, which we discussed in a previous publication (https://vidalquadrasramon.com/en/essentiality-assessment-of-seps-and-plans-of-the-commission/). One of such proposals relates to standard-essential patents (SEPs). Technical standards implemented worldwide, such as those relating to the different generations of mobile phone technologies (2G to …
INSIGHTS
General, Industrial Property, VQR
Vidal-Quadras&Ramon has been recognized one more year by the leading directory Chambers and Partners
Law and Technology
How to face cybersquatting
Industrial Property, Intellectual Property, Intellectual Property, Propiedad Industrial
